Evidence map›Paper›PMID 38067173›Full record

ReviewCells2023

Skin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties.

Paola Baker, Christina Huang, Rakan Radi, Samara B Moll, Emmanuela Jules, Jack L Arbiser

Abstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Phytochemical Profiling and Computational Screening ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Sprayable Hydrogel Dressings in Wound-Healing Applications.Bioengineering (Basel, Switzerland) · 2026
    Review

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paola BakerDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Christina HuangDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-1200-7520
Rakan RadiDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Samara B MollDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0009-0007-9553-5399
Emmanuela JulesDepartment of Dermatology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Jack L ArbiserMetroderm/United Derm Partners, 875 Johnson Ferry Road, Atlanta, GA 30342, USA.ORCID 0000-0002-6798-6383

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An intact barrier function of the skin is important in maintaining skin health. The regulation of the skin barrier depends on a multitude of molecular and immunological signaling pathways. By examining the regulation of a healthy skin barrier, including maintenance of the acid mantle and appropriate levels of ceramides, dermatologists can better formulate solutions to address issues that are related to a disrupted skin barrier. Conversely, by understanding specific skin barrier disruptions that are associated with specific conditions, such as atopic dermatitis or psoriasis, the development of new compounds could target signaling pathways to provide more effective relief for patients. We aim to review key factors mediating skin barrier regulation and inflammation, including skin acidity, interleukins, nuclear factor kappa B, and sirtuin 3. Furthermore, we will discuss current and emerging treatment options for skin barrier conditions.

Indexed as

Dermatitis, AtopicPsoriasisSkin DiseasesCeramidesHumansSkinCeramidesacid mantleatopic dermatitispsoriasisskin barrier

Identifiers

PMID38067173
PMCPMC10706187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.